Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Theravance Bio Ord (TBPH)

Theravance Bio Ord (TBPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Theravance Bio Ord 901 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080 CYM

www.theravance.com Employees: 99 P: 650-808-6000

Description:

Theravance Biopharma is a biopharmaceutical company primarily focused on discovering, developing and commercializing respiratory medicines. The company was formed following the split of the erstwhile Theravance into two listed companies in June 2014 - Innoviva, Inc. (then Theravance, Inc.) and Theravance.'

Key Statistics

Overview:

Market Capitalization, $K 490,265
Enterprise Value, $K 450,715
Shares Outstanding, K 49,174
Annual Sales, $ 57,420 K
Annual Net Income, $ -55,190 K
Last Quarter Sales, $ 16,870 K
Last Quarter Net Income, $ -12,700 K
EBIT, $ -44,000 K
EBITDA, $ -43,900 K
60-Month Beta 0.25
% of Insider Shareholders 6.90%
% of Institutional Shareholders 99.10%
Float, K 45,781
% Float 93.10%
Short Volume Ratio 0.11

Growth:

1-Year Return -3.86%
3-Year Return 24.47%
5-Year Return -54.18%
5-Year Revenue Growth -4.89%
5-Year Earnings Growth 74.94%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.06 on 11/12/24
Next Earnings Date N/A
Earnings Per Share ttm -1.01
EPS Growth vs. Prev Qtr 23.53%
EPS Growth vs. Prev Year -52.94%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

TBPH Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -24.79%
Return-on-Assets % -13.43%
Profit Margin % -96.12%
Debt/Equity 0.00
Price/Sales 8.49
Price/Cash Flow N/A
Price/Book 2.50
Book Value/Share 3.79
Interest Coverage -19.97
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar